vs
Side-by-side financial comparison of Edible Garden AG Inc (EDBL) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
Edible Garden AG Inc is the larger business by last-quarter revenue ($4.1M vs $3.9M, roughly 1.1× Opus Genetics, Inc.). On growth, Edible Garden AG Inc posted the faster year-over-year revenue change (6.6% vs -10.2%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs 14.8%).
Edible Garden AG Inc is a U.S.-based sustainable agricultural company specializing in hydroponically grown fresh organic herbs, leafy greens, and specialty vegetables. It distributes its pesticide-free produce to leading grocery retailers, food service operators, and direct-to-consumer platforms across North America, prioritizing eco-friendly, low-water farming practices.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
EDBL vs IRD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.1M | $3.9M |
| Net Profit | — | — |
| Gross Margin | -29.0% | — |
| Operating Margin | -138.6% | — |
| Net Margin | — | — |
| Revenue YoY | 6.6% | -10.2% |
| Net Profit YoY | — | 53.0% |
| EPS (diluted) | $-109.97 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.1M | $3.9M | ||
| Q3 25 | $2.8M | $3.1M | ||
| Q2 25 | $3.1M | $2.9M | ||
| Q1 25 | $2.7M | $4.4M | ||
| Q4 24 | $3.9M | $4.3M | ||
| Q3 24 | $2.6M | $3.9M | ||
| Q2 24 | $4.3M | $1.1M | ||
| Q1 24 | $3.1M | $1.7M |
| Q4 25 | — | — | ||
| Q3 25 | $-4.0M | $-17.5M | ||
| Q2 25 | $-4.0M | $-7.4M | ||
| Q1 25 | $-3.3M | $-8.2M | ||
| Q4 24 | $-3.1M | — | ||
| Q3 24 | $-2.1M | $-7.5M | ||
| Q2 24 | $-1.9M | $-7.8M | ||
| Q1 24 | $-4.0M | $-7.1M |
| Q4 25 | -29.0% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 20.2% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 36.7% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | -138.6% | — | ||
| Q3 25 | -126.3% | -269.9% | ||
| Q2 25 | -114.2% | -309.0% | ||
| Q1 25 | -107.7% | -227.2% | ||
| Q4 24 | -70.8% | — | ||
| Q3 24 | -57.7% | -207.1% | ||
| Q2 24 | -27.7% | -748.9% | ||
| Q1 24 | -123.3% | -450.5% |
| Q4 25 | — | — | ||
| Q3 25 | -143.6% | -566.9% | ||
| Q2 25 | -128.5% | -257.5% | ||
| Q1 25 | -122.3% | -187.5% | ||
| Q4 24 | -79.5% | — | ||
| Q3 24 | -79.8% | -194.6% | ||
| Q2 24 | -45.3% | -698.3% | ||
| Q1 24 | -127.0% | -415.3% |
| Q4 25 | $-109.97 | — | ||
| Q3 25 | $1.38 | $-0.25 | ||
| Q2 25 | $-6.58 | $-0.12 | ||
| Q1 25 | $-2.47 | $-0.24 | ||
| Q4 24 | $-330.78 | — | ||
| Q3 24 | $16.32 | $-0.29 | ||
| Q2 24 | $-30.02 | $-0.30 | ||
| Q1 24 | $-341.14 | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $45.1M |
| Total DebtLower is stronger | $1.7M | — |
| Stockholders' EquityBook value | $12.5M | $15.3M |
| Total Assets | $20.6M | $50.2M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $45.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | — | $32.4M | ||
| Q1 25 | — | $41.8M | ||
| Q4 24 | — | $30.3M | ||
| Q3 24 | — | $36.6M | ||
| Q2 24 | — | $41.4M | ||
| Q1 24 | — | $47.2M |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $12.5M | $15.3M | ||
| Q3 25 | $12.9M | $6.0M | ||
| Q2 25 | $1.6M | $17.5M | ||
| Q1 25 | $1.9M | $5.1M | ||
| Q4 24 | $4.1M | $6.7M | ||
| Q3 24 | $3.3M | $34.3M | ||
| Q2 24 | $511.0K | $40.6M | ||
| Q1 24 | $-4.1M | $46.1M |
| Q4 25 | $20.6M | $50.2M | ||
| Q3 25 | $20.1M | $36.1M | ||
| Q2 25 | $21.8M | $38.7M | ||
| Q1 25 | $8.5M | $48.2M | ||
| Q4 24 | $11.9M | $36.9M | ||
| Q3 24 | $8.9M | $40.4M | ||
| Q2 24 | $9.9M | $44.8M | ||
| Q1 24 | $6.3M | $51.8M |
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.24× | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-35.3M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -66.8% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | $-35.3M | ||
| Q3 25 | $-2.4M | $-6.2M | ||
| Q2 25 | $-3.4M | $-10.3M | ||
| Q1 25 | $-3.3M | $-9.0M | ||
| Q4 24 | $-1.8M | $-25.6M | ||
| Q3 24 | $-1.1M | $-5.1M | ||
| Q2 24 | $-4.6M | $-7.3M | ||
| Q1 24 | $-1.1M | $-5.7M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.8M | — | ||
| Q2 25 | $-3.5M | — | ||
| Q1 25 | $-3.4M | — | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-1.1M | — | ||
| Q2 24 | $-4.7M | — | ||
| Q1 24 | $-1.1M | — |
| Q4 25 | -66.8% | — | ||
| Q3 25 | -98.9% | — | ||
| Q2 25 | -110.8% | — | ||
| Q1 25 | -125.5% | — | ||
| Q4 24 | -48.6% | — | ||
| Q3 24 | -43.4% | — | ||
| Q2 24 | -110.2% | — | ||
| Q1 24 | -35.6% | — |
| Q4 25 | 2.3% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 0.4% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 1.8% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EDBL
| Herbs Produce Floral | $3.6M | 86% |
| Other | $576.0K | 14% |
IRD
Segment breakdown not available.
